Gennex Laboratories submits FY26 annual report ahead of September AGM
- Gennex Laboratories submitted its 41st Annual Report for FY26 to stock exchanges
- The filing includes financial statements and the AGM notice per SEBI LODR Regulation 34
- The annual general meeting is scheduled for September 30, 2026, via video conferencing
- E-voting facility is provided by NSDL with a cut-off date of September 23, 2026
*this image is generated using AI for illustrative purposes only.
Gennex Laboratories has submitted its 41st Annual Report for the financial year ended March 31, 2026, to stock exchanges. The filing includes the notice for the annual general meeting scheduled for September 30, 2026.
The company filed the documents in compliance with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The submission was made to BSE Limited, Ahmedabad Stock Exchange Limited, and Calcutta Stock Exchange Limited.
Annual Report Contents
The annual report contains several key documents for shareholders:
- Notice of the Annual General Meeting.
- Director's Report.
- Independent Audit Report of the Statutory Auditor.
- Financial Statements (Standalone and Consolidated), including Balance Sheet, Statement of Profit and Loss account, and Cash Flow Statement with notes.
These documents have been sent electronically to members who have registered their email IDs as per SEBI guidelines. They are also available on the company website and for inspection at the registered office during office hours.
Meeting Logistics
The 41st AGM is scheduled for Wednesday, September 30, 2026, at 12:30 pm. The event will be conducted through video conferencing or other audio-visual means (VC/OAVM). Ms. Sweety Kapoor, a practicing company secretary based in Kolkata, has been appointed as the scrutinizer for the meeting.
National Securities Depository Limited (NSDL) serves as the authorized agency to facilitate the AGM and provide e-voting facilities. The e-voting period runs from Sunday, September 27, 2026, at 9:00 am to Tuesday, September 29, 2026, at 5:00 pm. The cut-off date for voting eligibility is September 23, 2026.
The book closure period coincides with the meeting date, running from September 23, 2026, to September 30, 2026. Shareholders holding equity shares within this window are eligible to vote.
Audit Approvals
The board previously approved two critical audit reports for the fiscal year ended March 31, 2026:
- Secretarial Audit Report issued by Mr. Md. Tausif Shamim, practicing company secretary in Kolkata.
- Cost Audit Report issued by M/s. Sai Krishna & Associates, cost accountants.
These approvals ensure regulatory compliance under Regulation 30 of the SEBI (LODR) Regulations, 2015.
Historical Stock Returns for Gennex Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.02% | -1.33% | -15.69% | -2.03% | -20.41% | +36.97% |
What specific growth initiatives or capital allocation strategies are outlined in the Director's Report for the upcoming fiscal year?
How do the consolidated financial results for FY2026 compare to analyst expectations, and what does this imply for near-term stock valuation?
Are there any proposed changes to dividend policy or share buyback plans that shareholders should anticipate at the AGM?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
